KYMR
Price
$75.82
Change
-$1.88 (-2.42%)
Updated
Feb 5, 04:59 PM (EDT)
Capitalization
6.07B
13 days until earnings call
Intraday BUY SELL Signals
NRIX
Price
$15.94
Change
-$0.61 (-3.69%)
Updated
Feb 5, 04:59 PM (EDT)
Capitalization
1.64B
67 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

KYMR vs NRIX

Header iconKYMR vs NRIX Comparison
Open Charts KYMR vs NRIXBanner chart's image
Kymera Therapeutics
Price$75.82
Change-$1.88 (-2.42%)
Volume$18.76K
Capitalization6.07B
Nurix Therapeutics
Price$15.94
Change-$0.61 (-3.69%)
Volume$23.55K
Capitalization1.64B
KYMR vs NRIX Comparison Chart in %
View a ticker or compare two or three
VS
KYMR vs. NRIX commentary
Feb 06, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KYMR is a Buy and NRIX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 06, 2026
Stock price -- (KYMR: $77.70 vs. NRIX: $16.55)
Brand notoriety: KYMR and NRIX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KYMR: 79% vs. NRIX: 59%
Market capitalization -- KYMR: $6.07B vs. NRIX: $1.64B
KYMR [@Biotechnology] is valued at $6.07B. NRIX’s [@Biotechnology] market capitalization is $1.64B. The market cap for tickers in the [@Biotechnology] industry ranges from $116.41B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KYMR’s FA Score shows that 0 FA rating(s) are green whileNRIX’s FA Score has 1 green FA rating(s).

  • KYMR’s FA Score: 0 green, 5 red.
  • NRIX’s FA Score: 1 green, 4 red.
According to our system of comparison, NRIX is a better buy in the long-term than KYMR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KYMR’s TA Score shows that 4 TA indicator(s) are bullish while NRIX’s TA Score has 3 bullish TA indicator(s).

  • KYMR’s TA Score: 4 bullish, 5 bearish.
  • NRIX’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, KYMR is a better buy in the short-term than NRIX.

Price Growth

KYMR (@Biotechnology) experienced а +9.19% price change this week, while NRIX (@Biotechnology) price change was -7.39% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -7.10%. For the same industry, the average monthly price growth was -2.90%, and the average quarterly price growth was +28.24%.

Reported Earning Dates

KYMR is expected to report earnings on Feb 19, 2026.

NRIX is expected to report earnings on Apr 14, 2026.

Industries' Descriptions

@Biotechnology (-7.10% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($6.07B) has a higher market cap than NRIX($1.64B). KYMR YTD gains are higher at: -0.141 vs. NRIX (-12.757). NRIX has higher annual earnings (EBITDA): -248.7M vs. KYMR (-286.52M). KYMR has more cash in the bank: 506M vs. NRIX (429M). NRIX has less debt than KYMR: NRIX (56.5M) vs KYMR (84M). NRIX has higher revenues than KYMR: NRIX (83.7M) vs KYMR (43.7M).
KYMRNRIXKYMR / NRIX
Capitalization6.07B1.64B370%
EBITDA-286.52M-248.7M115%
Gain YTD-0.141-12.7571%
P/E RatioN/AN/A-
Revenue43.7M83.7M52%
Total Cash506M429M118%
Total Debt84M56.5M149%
TECHNICAL ANALYSIS
Technical Analysis
KYMRNRIX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
79%
Momentum
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bullish Trend 3 days ago
83%
N/A
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 11 days ago
80%
Declines
ODDS (%)
Bearish Trend 18 days ago
86%
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
88%
Aroon
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
KYMR
Daily Signal:
Gain/Loss:
NRIX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IASAX10.510.19
+1.84%
VY® American Century Sm-Mid Cp Val A
GLDCX47.830.30
+0.63%
Gabelli Gold C
PQDMX17.750.02
+0.11%
PGIM Quant Solutions Intl Dev Mkts IdxR6
OEICX101.83-0.52
-0.51%
JPMorgan Equity Index C
NGDCX28.50-0.33
-1.14%
Neuberger Large Cap Growth C

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with VERA. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then VERA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
+0.62%
VERA - KYMR
65%
Loosely correlated
-4.32%
NRIX - KYMR
65%
Loosely correlated
-1.43%
NUVL - KYMR
63%
Loosely correlated
-2.03%
IMVT - KYMR
61%
Loosely correlated
-2.52%
TBPH - KYMR
60%
Loosely correlated
+0.50%
More

NRIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRIX has been closely correlated with KYMR. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if NRIX jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRIX
1D Price
Change %
NRIX100%
-1.43%
KYMR - NRIX
72%
Closely correlated
+0.62%
SYRE - NRIX
70%
Closely correlated
-3.66%
TRDA - NRIX
70%
Closely correlated
-8.23%
IMNM - NRIX
70%
Closely correlated
-2.08%
ERAS - NRIX
69%
Closely correlated
+6.19%
More